# Celsius Holdings, Inc.: Form 10-Q for the period ended Sep 30, 2022

- Company: [Celsius Holdings, Inc.](/companies/celh.md) (CIK 1341766)
- Form: 10-Q
- Filed: 2022-11-09
- Accepted by EDGAR: Nov 9, 2022, 16:01 ET
- Period: 2022-09-30
- Accession: 0000950170-22-023818
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1341766/000095017022023818/celh-20220930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1341766/000095017022023818/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-07-01 to 2022-09-30 | $188.2m | us-gaap:Revenues |
| Revenue | 9 months, 2022-01-01 to 2022-09-30 | $475.6m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2022-07-01 to 2022-09-30 | $109.6m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2022-01-01 to 2022-09-30 | $283.8m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2022-07-01 to 2022-09-30 | $78.7m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2022-01-01 to 2022-09-30 | $191.9m | us-gaap:GrossProfit |
| Research and development | 3 months, 2022-07-01 to 2022-09-30 | $100.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2022-01-01 to 2022-09-30 | $300.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2022-07-01 to 2022-09-30 | −$147.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2022-01-01 to 2022-09-30 | −$125.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2022-07-01 to 2022-09-30 | −$35.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2022-01-01 to 2022-09-30 | −$41.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-07-01 to 2022-09-30 | −$181.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2022-01-01 to 2022-09-30 | −$166.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-07-01 to 2022-09-30 | −$2.46 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2022-01-01 to 2022-09-30 | −$2.26 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-07-01 to 2022-09-30 | −$2.46 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2022-01-01 to 2022-09-30 | −$2.26 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-07-01 to 2022-09-30 | 75,796,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2022-01-01 to 2022-09-30 | 75,625,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2022-01-01 to 2022-09-30 | $171.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2022-01-01 to 2022-09-30 | $3.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2022-09-30 | $592.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-09-30 | $1.03bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-09-30 | $1.33bn | us-gaap:Assets |
| Current liabilities | at 2022-09-30 | $271.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-09-30 | $443.7m | us-gaap:Liabilities |
| Shareholders' equity | at 2022-09-30 | $883.9m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 22,997 characters.

When used in this report, unless otherwise indicated, the terms “the Company,” “Celsius,” “we,” “us” and “our” refer to Celsius Holdings, Inc. and its subsidiaries.

### Note Regarding Forward Looking Statements

This report contains forward-looking statements that reflect our current views about future events. We use the words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

Our forward-looking statements may include, but are not limited to, statements about:

- our expectations relating to expansion into additional geographic markets and product lines;
- our expectations relating to revenue, operating costs and profitability;
- our expectations regarding our strategy and investments;
- our expectations regarding our business, including market opportunity, consumer demand and our competitive advantage;
- our expectations regarding supply chains and distribution networks;
- the impact of future and existing food and drug laws and regulations on our business;
- our expectations regarding cost and availability of materials and ingredients;
- our expectations regarding our future growth prospects and our ability manage our growth and hire capable personnel to support our growth;
- the potential ongoing impact of the continuing COVID-19 pandemic on us directly, or on our distributors or suppliers;
- expected competition from the functional energy drink and supplement industries and other sources;
- our expectations relating to marketing and advertising expense;
- the timing of our receipt and recognition of revenues and other payments;
- our expectations about our trademarks and trade secrets;
- our expectations relating to macroeconomic conditions;
- general economic and business conditions in particular industries, markets or geographic regions, as well the potential for a significant economic slowdown, stagflation or economic recession;
- political unrest and military actions in foreign countries, particularly the armed conflict in Ukraine, as well as the impact on world markets and energy supplies resulting therefrom;
- our critical accounting policies and related estimates or changes in accounting practices;
- our liquidity and capital needs;
- political, legislative, regulatory and legal challenges;
- the merits or potential impact of any lawsuits filed against us or disputes we may be party to; and
- other statements regarding our future operations, financial condition, prospects and business strategies.

These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including but not limited to: our ability to successfully make and integrate acquisitions; the impact on our operations of public health crises, including of the current coronavirus outbreak; and the performance, reliability and availability of our ecommerce platform and underlying network infrastructure.

### Business Overview

Celsius is a fast-growing company in the functional energy drink and liquid supplement categories in the United States and internationally. We engage in the development, processing, marketing, sale, and distribution of functional drinks and liquid supplements to a broad range of consumers. We believe that we provide differentiated products that offer clinically proven and innovative formulas meant to change the lives of our consumers for the better. We also believe that our brand is attractive to a broad range of customers including fitness enthusiasts.

Our core offerings include pre- and post-workout functional energy drinks, as well as protein bars. Our flagship functional energy drink and liquid supplement brands are backed by science, being clinically proven to deliver health benefits by six self-funded studies published in various journals including the Journal of the International Society of Sports Nutrition, the Journal of the American College of Nutrition, and the Journal of Strength and Conditioning Research. These studies have concluded that a single serving of Celsius burns 100-140 calories (by increasing a consumer’s resting metabolism an average of 12%, while providing sustained energy for up to three hours).

Our flagship asset, Celsius, is a fitness supplement drink which accelerates metabolism and burns calories and body fat while providing energy. This product line comes in two versions, a ready-to-drink supplement format and an on-the-go powder form. We also offer a Celsius Heat and a Branch Chain Amino Acids line, catered to both pre- and post-workout consumer needs. Our products are currently offered in major retail channels in the US including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce.

An integral part of our value proposition is our focus on the functional energy drink and liquid supplement category, ensuring our products have clear and proven benefits. This is why we invest in research and development from the start and utilize our proprietary MetaPlus formulation in our portfolio, a blend of ginger root, guarana seed extract, chromium, vitamins, and green tea extract.

### Results of Operations

### Three months ended September 30, 2022 compared to three months ended September 30, 2021

### Revenue

For the three months ended September 30, 2022, revenue was approximately $188.2 million, an increase of $93.3 million or 98% from $94.9 million for the three months ended September 30, 2021. Approximately 102% of this growth was as a result of increased revenues from North America, where third quarter 2022 revenues were $179.5 million, an increase of $95.1 million or 112% from the same period in 2021. The balance of the revenues for the three months ended September 30, 2022 quarter were mainly attributable to European revenues of $7.5 million, which decreased by $2.0 million from the same period in 2021 due to foreign exchange rates and timing of new product launches and continuing supply chain challenges. Asian revenues (which include royalty revenues from our China licensee) contributed an additional approximately $1.0 million, an increase of 37% from approximately $0.7 million for the same period in 2021, which include increases in royalties payable under our licensing agreement. Other international markets generated approximately $0.2 million in revenues during the three months ended September 30, 2022 , an increase of 3% from $0.2 million for the same period in 2021.

The total increase in revenue was largely attributable to increases in sales volume, as opposed to increases in product pricing. The primary factors behind the increase in North American sales volume were related to continued strong triple-digit growth in traditional distribution channels, combined with an increase in and optimization of our products’ presence in world class retailers (e.g., additional SKUs). Additionally, revenues increased as a result of building inventories at Pepsi warehouses and distribution centers in anticipation of the transition to the Pepsi distribution network resulting in delivery of approximately five million raw cases. These revenues were offset by the prior distribution network which reduced their inventory balances at both their distribution centers and within their network as a majority of the prior distribution system was terminated as of September 30, 2022.

The following table sets forth the amount of revenues by category and changes therein for the three months ended September 30, 2022 and 2021 (dollars in thousands):

| Revenue Source | For the three months ended September 30, 2022 | 2021 | Change |
| --- | ---: | ---: | ---: |
| Total Revenue | $188,233 | $94,909 | 98.3% |
| North American Revenue | $179,541 | $84,490 | 112.5% |
| European Revenue | $7,546 | $9,536 | (20.9)% |
| Asian Revenue | $964 | $706 | 36.5% |
| Other | $182 | $177 | 2.8% |

### Gross profit

For the three months ended September 30, 2022, gross profit increased by approximately $41.0 million or 109% to $78.7 million, from approximately $37.7 million for the three months ended September 30, 2021. Gross profit margins reflected an increase to 41.8% for the three months ended September 30, 2022 from 39.7% for the same period in 2021 reflecting a 210 basis point improvement. Efficiencies in outbound freight, which were partially offset by volatility in fuel prices, generated 130 basis points of improvement, while average case costs drove improvements in raw material costs.

### Sales and marketing expenses

Sales and marketing expenses for the three months ended September 30, 2022 were approximately $198.8 million, an increase of approximately $176.1 million or 779% from approximately $22.6 million for the three months ended September 30, 2021. This increase was primarily attributable to expense for termination fees paid to prior distributors, which resulted in an increase of $155.4 million when compared to the prior year quarter. Additionally, employee costs increased by approximately $1.1 million from the year ago quarter as we continue to invest in this area in order to have the proper infrastructure to support our growth. Marketing costs also increased by approximately $14.6 million as we expanded our footprint in stores across the United States. Lastly, storage and distribution expenses as well as broker costs accounted for the remainder of the increase in this area in the amount of $4.4 million from the 2021 quarter to the 2022 quarter.

### General and administrative expenses

General and administrative expenses for the three months ended September 30, 2022 were approximately $27.5 million, an increase of $4.2 million or 18%, from $23.3 million for the three months ended September 30, 2021. Employee costs for the three months ended September 30, 2022 reflect an increase of $0.9 million as investments in this area are also required to properly support our higher business volume and the commercial and operational areas of the business, as well as travel expenses are now being incurred. Depreciation, amortization and impairment expenses increased by approximately $2.4 million when compared to the prior year quarter. These increases were offset by a $11.7 million decrease in stock-based compensation expense, which amounted to $6.3 million in the current quarter, when compared to the prior year quarter. Management deems it very important to motivate employees by providing them ownership in the business in order to promote over performance which translates into the continued success of our business based on key performance attributes. Administration expenses also increased by $12.3 million primarily due to a litigation settlement in the amount of $7.8 million as well as increased costs associated with third party service providers including audit fees, internal control and Sox compliance, and other litigation. Lastly, all other administrative expenses which were mainly composed of research, development and quality control testing, increased by approximately $0.3 million from to the second quarter of 2021.

### Other income/(expense)

Total net other expense for the three months ended September 30, 2022 is mainly related to foreign currency exchange which is offset by interest and non-operating income.

### Net Loss

Net loss attributable to common shareholders for the three months ended September 30, 2022 was $186.5 million or $2.46 per share based on a weighted average of approximately 75,796,000 shares outstanding. The dilutive impact share-based awards of 10,185,781 shares, were excluded from the calculations due to the net loss position of the Company. In comparison, for the three months ended September 30, 2021, the Company had a net loss of approximately $9.4 million or $0.13 per share, based on a weighted average of 74,609,000 shares outstanding.

### Nine months ended September 30, 2022 compared to nine months ended September 30, 2021

### Revenue

For the nine months ended September 30, 2022, revenue was approximately $475.6 million, an increase of $265.6 million or 126% from $210.0 million for the nine months ended September 30, 2021. Approximately 102% of this growth was as a result of increased revenues from North America, where the first nine months of 2022 revenues were $448.1 million, an increase of $271.0 million or 153% from the 2021 first nine months. The balance of the revenues for the nine months ended September 30, 2022 were mainly attributable to European revenues of $23.5 million, which decreased by $7.2 million from the prior year nine months primarily due to foreign exchange rates and timing of new product launches and continuing supply chain challenges. Asian revenues (which include royalty revenues from our China licensee) contributed an additional approximately $2.9 million, an increase of 54% from approximately $1.9 million for the prior year, which include increases in royalties payable under our licensing agreement. Other international markets generated approximately $1.1 million in revenues during the nine months ended September 30, 2022, an increase of $0.7 million or 200.3% from $0.4 million for the prior year.

The total increase in revenue was largely attributable to increases in sales volume, as opposed to increases in product pricing. The primary factors behind the increase in North American sales volume were related to continued strong triple-digit growth in traditional distribution channels, combined with an increase in and optimization of our products’ presence in world class retailers (e.g., additional SKUs). Additionally, revenues increased as a result of building inventories at Pepsi warehouses and distribution centers in anticipation of the transition to the Pepsi distribution network resulting in delivery of approximately five million raw cases. These revenues were offset by the prior distribution network which reduced their inventory balances at both their distribution centers and within their network as a majority of the prior distribution system was terminated as of September 30, 2022.

The following table sets forth the amount of revenues by category and changes therein for the nine months ended September 30, 2022 and 2021 (dollars in thousands):

| Revenue Source | For the nine months ended September 30, 2022 | 2021 | Change |
| --- | ---: | ---: | ---: |
| Total Revenue | $475,640 | $210,017 | 126.5% |
| North American Revenue | $448,141 | $177,094 | 153.1% |
| European Revenue | $23,540 | $30,695 | (23.3)% |
| Asian Revenue | $2,857 | $1,861 | 53.5% |
| Other | $1,102 | $367 | 200.3% |

30

### Gross profit

For the nine months ended September 30, 2022, gross profit increased by approximately $105.3 million or 122% to $191.9 million, from $86.5 million for the nine months ended September 30, 2021. Gross profit margins reflected a decrease to 40.3% for the nine months ended September 30, 2022 from 41.2% for the nine months ended September 30, 2021, reflecting a 90 basis point reduction. Efficiencies in outbound freight, which were partially offset by volatility in fuel prices, generated 310 basis points of improved margin, which was more than offset by higher raw material costs including aluminum cans, ocean freight costs and packing costs.

### Sales and marketing expenses

Sales and marketing expenses for the nine months ended September 30, 2022 were approximately $262.8 million, an increase of approximately $212.7 million or 424% from approximately $50.1 million for the nine months ended September 30, 2021. This increase was partially attributable to higher marketing investment activities, which resulted in an increase of $31.2 million when compared to the prior year. Additionally, employee costs increased by approximately $5.9 million from the prior year as we continue to invest in this area in order to have the proper infrastructure to support our growth. Costs related to expense for termination fees to prior distributors, resulted in an increase of $156.2 million when compared to the prior year. Lastly, storage and distribution expenses as well as broker costs accounted for the remainder of the increase in this area in the amount of $19.4 million from the nine months ended September 30, 2021.

### General and administrative expenses

General and administrative expenses for the nine months ended September 30, 2022 were approximately $54.1 million, an increase of $10.8 million or 25%, from $43.4 million for the nine months ended September 30, 2021. This increase was primarily attributable to employee costs for the nine months ended September 30, 2022 which reflect an increase of $3.1 million, as investments in this area are also required to properly support our higher business volume and the commercial and operational areas of the business, as well as travel expenses are now being incurred. Depreciation, amortization, and impairment expenses increased by approximately $2.7 million when compared to the prior year quarter. These increases were offset by a $13.6 million decrease in stock-based compensation expense which amounted to $14.8 million for the nine months ended September 30, 2022, compared to $28.7 million in the prior year quarter. Management deems it very important to motivate employees by providing them ownership in the business in order to promote over performance which translates into the continued success of our business based on key performance attributes. Administrative expense also increased by $18.9 million primarily due to a litigation settlement in the amount of $7.8 million as well as increased costs associated with third party service providers including audit fees, internal control and Sox compliance and other litigation. Lastly, all other administrative expenses which were mainly composed of research, development and quality control testing, decreased by approximately $0.3 million during the nine months ended September 30, 2021.

### Other income/(expense)

Total net other expense for the nine months ended September 30, 2022 is mainly related to foreign currency exchange which is offset by interest and non-operating income.

### Net Loss

Net loss attributable to common shareholders for the nine months ended September 30, 2022 was $170.7 million or $2.26 per share based on a weighted average of approximately 75,625,000 shares outstanding. The dilutive impact share-based awards of 10,229,657 shares, were excluded from the calculation due to the net loss position of the Company. In comparison, for the nine months ended September 30, 2021, the Company had net loss of approximately $8 million or $0.11 per share, based on a weighted average of approximately 73,759,000 shares outstanding.

### Liquidity and Capital Resources

As of September 30, 2022, and December 31, 2021, we had cash of approximately $727 million (including restricted cash of $135 million) and $16.3 million, respectively, and working capital of approximately $755.7 million and $169.2 million, respectively.

In addition to cash flow from operations, our primary sources of working capital have been private placements and public offerings of our securities, including an underwritten public offering of 1,133,953 shares at an offering price of $62.50 per share completed in June 2021 and a private placement of 1,466,666 Series A convertible shares as part of our agreement with Pepsi at a price of $375 per share, completed in August of 2022.

Our current operating plan for the next twelve (12) months reflects sufficient financial resources.

### Cash flows provided by operating activities

Cash flows provided by operating activities totaled approximately $171.0 million for the nine months ended September 30, 2022, which compares to $52.1 million net cash used in operating activities for the nine months ended September 30, 2021. The approximately $223.0 million increase in cash generation was driven by the timing of cash receipts and payments associated with the Pepsi transition as well as continued growth in the operations of the Company.

### Cash flows used in investing activities

Cash flows used in investing activities totaled approximately $0.9 million for the nine months ended September 30, 2022, which compares to cash used in investing activities of $0.5 million for the nine months ended September 30, 2021. The increase in the cash used in investing activities when compared to the 2021 period was primarily due to an increase of capital expenditures to $3.5 million offset by payment on our note receivable, as we received payment on our note receivable of approximately $2.6 million in April 2022.

### Cash flows provided by financing activities

Cash flows provided by financing activities totaled approximately $540.5 million for the nine months ended September 30, 2022, which compares to cash provided by financing activities of $70.9 million for the nine months ended September 30, 2021. Cash provided by financing activities is mainly related to the net proceeds of $542 million from issuances of Series A convertible preferred shares related to Pepsi, net of issuance costs. Net proceeds were received from a public offering in June 2021 for approximately $67.8 million.

### Off Balance Sheet Arrangements

As of September 30, 2022 and December 31, 2021, we had no off-balance sheet arrangements.

### Critical Accounting Policies and Estimates

Our consolidated financial statements are prepared in accordance with US GAAP, which requires us to make estimates and assumptions that affect the reported amounts in our consolidated financial statements. Critical accounting estimates are those that management believes are the most important to the portrayal of our financial condition and results and require the most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and that have had, or are reasonably likely to have, a material impact on our financial condition or results of operations. Judgments and uncertainties may result in materially different amounts being reported under different conditions or using different assumptions. There have been no material changes to our critical accounting policies or estimates from the information provided in “Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Part II, Item 8 – Financial Statements and Supplementary Data – Note 2”, included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

## Market risk

As filed, 1,062 characters.

In the normal course of business our financial position is routinely subject to a variety of risks. The principal market risks (i.e., the risk of loss arising from adverse changes in market rates and prices) to which we are exposed are fluctuations in commodity and other input prices affecting the costs of our raw materials (including, but not limited to, increases in the costs of the price of aluminum cans, sucralose and other sweeteners, as well as other raw materials contained within our products). We generally do not use hedging agreements or alternative instruments to manage the risks associated with securing sufficient ingredients or raw materials. We are also subject to market risks with respect to the cost of commodities and other inputs because our ability to recover increased costs through higher pricing is limited by the competitive environment in which we operate.

We do not use derivative financial instruments to protect ourselves from fluctuations in interest rates and generally do not hedge against fluctuations in commodity prices.

## Controls and procedures

As filed, 7,648 characters.

### Management’s Report on Disclosure Controls and Procedures

Our Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial and accounting officer), conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of September 30, 2022, to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms adopted by the SEC, including to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Our Chief Executive Officer and our Chief Financial Officer do not expect that our disclosure controls or internal controls will prevent all error and all fraud. Although our disclosure controls and procedures were designed to provide reasonable assurance of achieving their objectives and our Chief Executive Officer and our Chief Financial Officer are evaluating whether our disclosure controls and procedures are effective at doing so, a control system, no matter how well conceived and operated, can provide only reasonable, not absolute assurance that the objectives of the system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented if there exists in an individual a desire to do so. There can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

We identified material weaknesses as of December 31, 2021 in our internal controls over financial reporting, which were not fully remedied as of September 30, 2022. A material weakness is a deficiency or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected and corrected on a timely basis. As a result of these material weaknesses, we concluded that internal controls over the following areas were not effective as of December 31, 2021 and were not fully remedied as of September 30, 2022.

a) Management failed to design effective controls related to the application of U.S. GAAP guidance in their evaluation of modifications to share-based payment arrangements, resulting in the correction of errors in previously issued interim financial statements relating to the recognition of compensation expense;

b) For a substantial portion of the year, management did not design and maintain effective controls over information technology general controls (ITGCs) for information systems and applications that are relevant to the preparation of the consolidated financial statements. Specifically, management did not design and maintain: sufficient user access controls to ensure appropriate segregation of duties and adequately restrict user and privileged access to financial applications, programs and data to appropriate Company personnel; program change management controls to ensure that information technology (IT) program and data changes affecting financial information technology applications and underlying accounting records are authorized, tested, and implemented appropriately. As a result, business process controls (automated and it-dependent manual controls) that are dependent on the ineffective ITGCs, or that use data produced from systems impacted by the ineffective ITGCs were deemed ineffective at December 31 2021; and

c) Management did not have an adequate process in place to monitor and provide oversight over the completion of its testing and assessment of the design and operating effectiveness of internal control over financial reporting in a timely manner. As such, we determined that management failed to fully implement components of the COSO framework, including elements of the control environment, information and communication, control activities and monitoring activities components, relating to: (i) providing sufficient and timely management oversight and ownership over the internal control evaluation process; (ii) hiring and training sufficient personnel to timely support the Company’s internal control objectives; (iii) performing timely monitoring and oversight to ascertain whether the components of internal control are present and functioning effectively.

To address the issues associated with our material weaknesses as described above, management is re-assessing the design of controls and modifying processes designed to improve our internal control over financial reporting and remediate the control deficiencies that led to the material weaknesses, including but not limited to, (a) enhancing monitoring and oversight controls in the application of U.S. GAAP guidance pertaining to modifications of share-based payments, (b) hiring additional accounting and IT personnel with appropriate technical skillsets, (c) improving consistency in change management supported by standard operating procedures to govern the authorization, testing and approval of changes to information technology systems supporting all of the Company’s internal control processes, (d) enhancing design and implementation of our control environment, including the expansion of formal accounting and IT policies and procedures and financial reporting controls, and (e) implementing appropriate timely review and oversight responsibilities within the accounting and financial reporting functions. However, as of September 30, 2022, the identified material weaknesses were not fully remedied.

### Changes in Internal Controls Over Financial Reporting

During the nine months ended September 30, 2022, we have been implementing and will aggressively continue to implement changes that are both organizational and process-focused to improve the control environment. We anticipate the actions to be taken, and resulting process improvements, to generally strengthen our internal controls over financial reporting, information technology general controls as well as our controls around share-based payments, and over time, will address the material weaknesses noted as of December 31, 2021. These remedial measures were considered changes to our internal control environment which had a material effect on internal control over financial reporting. However, because certain of the remedial actions have only recently been undertaken and others will occur over the next several months, we have concluded that our controls and procedures in the areas listed above were not effective as of September 30, 2022. We will not be able to conclude whether the material weaknesses have been eliminated until the completion of the December 31, 2022 annual report on Form 10-K.

Filed Nov 9, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-023818. Last ingested by Listed: Nov 10, 2026, 02:33 ET. No prices; not investment advice.
